These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28462988)

  • 1. Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse Brain.
    Nikan M; Osborn MF; Coles AH; Biscans A; Godinho BMDC; Haraszti RA; Sapp E; Echeverria D; DiFiglia M; Aronin N; Khvorova A
    Bioconjug Chem; 2017 Jun; 28(6):1758-1766. PubMed ID: 28462988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier.
    Godinho BMDC; Henninger N; Bouley J; Alterman JF; Haraszti RA; Gilbert JW; Sapp E; Coles AH; Biscans A; Nikan M; Echeverria D; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2018 Nov; 26(11):2580-2591. PubMed ID: 30143435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain.
    Nikan M; Osborn MF; Coles AH; Godinho BM; Hall LM; Haraszti RA; Hassler MR; Echeverria D; Aronin N; Khvorova A
    Mol Ther Nucleic Acids; 2016 Aug; 5(8):e344. PubMed ID: 27504598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing.
    Didiot MC; Hall LM; Coles AH; Haraszti RA; Godinho BM; Chase K; Sapp E; Ly S; Alterman JF; Hassler MR; Echeverria D; Raj L; Morrissey DV; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2016 Oct; 24(10):1836-1847. PubMed ID: 27506293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.
    Godinho BMDC; Gilbert JW; Haraszti RA; Coles AH; Biscans A; Roux L; Nikan M; Echeverria D; Hassler M; Khvorova A
    Nucleic Acid Ther; 2017 Dec; 27(6):323-334. PubMed ID: 29022758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo.
    Biscans A; Coles A; Haraszti R; Echeverria D; Hassler M; Osborn M; Khvorova A
    Nucleic Acids Res; 2019 Feb; 47(3):1082-1096. PubMed ID: 30544191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles.
    Haraszti RA; Miller R; Didiot MC; Biscans A; Alterman JF; Hassler MR; Roux L; Echeverria D; Sapp E; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2018 Aug; 26(8):1973-1982. PubMed ID: 29937418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin-siRNA conjugates as versatile gene silencing agents.
    Malhotra M; Gooding M; Evans JC; O'Driscoll D; Darcy R; O'Driscoll CM
    Eur J Pharm Sci; 2018 Mar; 114():30-37. PubMed ID: 29191522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
    Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
    J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery.
    Chen Q; Butler D; Querbes W; Pandey RK; Ge P; Maier MA; Zhang L; Rajeev KG; Nechev L; Kotelianski V; Manoharan M; Sah DW
    J Control Release; 2010 Jun; 144(2):227-32. PubMed ID: 20170694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.
    Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR
    Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain.
    Alterman JF; Hall LM; Coles AH; Hassler MR; Didiot MC; Chase K; Abraham J; Sottosanti E; Johnson E; Sapp E; Osborn MF; Difiglia M; Aronin N; Khvorova A
    Mol Ther Nucleic Acids; 2015 Dec; 4(12):e266. PubMed ID: 26623938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation.
    Lau S; Graham B; Cao N; Boyd BJ; Pouton CW; White PJ
    Mol Pharm; 2012 Jan; 9(1):71-80. PubMed ID: 22141328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system.
    Alterman JF; Godinho BMDC; Hassler MR; Ferguson CM; Echeverria D; Sapp E; Haraszti RA; Coles AH; Conroy F; Miller R; Roux L; Yan P; Knox EG; Turanov AA; King RM; Gernoux G; Mueller C; Gray-Edwards HL; Moser RP; Bishop NC; Jaber SM; Gounis MJ; Sena-Esteves M; Pai AA; DiFiglia M; Aronin N; Khvorova A
    Nat Biotechnol; 2019 Aug; 37(8):884-894. PubMed ID: 31375812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model.
    Mendonça MCP; Cronin MF; Cryan JF; O'Driscoll CM
    Eur J Pharm Biopharm; 2021 Dec; 169():309-318. PubMed ID: 34793942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.
    DiFiglia M; Sena-Esteves M; Chase K; Sapp E; Pfister E; Sass M; Yoder J; Reeves P; Pandey RK; Rajeev KG; Manoharan M; Sah DW; Zamore PD; Aronin N
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17204-9. PubMed ID: 17940007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel lysophosphatidic acid acyltransferase enzyme (LPAAT4) with a possible role for incorporating docosahexaenoic acid into brain glycerophospholipids.
    Eto M; Shindou H; Shimizu T
    Biochem Biophys Res Commun; 2014 Jan; 443(2):718-24. PubMed ID: 24333445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA conjugate delivery systems.
    Jeong JH; Mok H; Oh YK; Park TG
    Bioconjug Chem; 2009 Jan; 20(1):5-14. PubMed ID: 19053311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.
    Chong RH; Gonzalez-Gonzalez E; Lara MF; Speaker TJ; Contag CH; Kaspar RL; Coulman SA; Hargest R; Birchall JC
    J Control Release; 2013 Mar; 166(3):211-9. PubMed ID: 23313112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.